A retrospective study of demographics, clinical characteristics, and treatment patterns for US patients with chronic or episodic migraine (CM/EM) initiating fremanezumab treatment
Latest Information Update: 01 Aug 2021
At a glance
- Drugs Fremanezumab (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 06 Jun 2021 Results presented at the 63rd Annual Scientific Meeting of the American Headache Society
- 04 Jun 2021 New trial record
- 22 Apr 2021 Results presented at the 73rd Annual Meeting of the American Academy of Neurology